Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	ConA-like_dom	LAMA3 TRIM39 RYR1 RYR3 FAT1 BTN1A1 COL14A1 HERC1 USH2A	2.92e-05	219	134	9	IPR013320
Domain	Cyt_P450_E_grp-I_CYP1	CYP1A1 CYP1A2	5.11e-05	2	134	2	IPR008066
Domain	Ryanodine_rcpt	RYR1 RYR3	1.53e-04	3	134	2	IPR003032
Domain	Ryanrecept_TM4-6	RYR1 RYR3	1.53e-04	3	134	2	IPR009460
Domain	RyR	RYR1 RYR3	1.53e-04	3	134	2	PF02026
Domain	RR_TM4-6	RYR1 RYR3	1.53e-04	3	134	2	PF06459
Domain	Ryan_recept	RYR1 RYR3	1.53e-04	3	134	2	IPR013333
Domain	CYSTEINE_SWITCH	ADAMTS12 ADAMTS16 ADAMTS18 MMP16	2.09e-04	41	134	4	PS00546
Domain	Pept_M10_metallopeptidase	ADAMTS12 ADAMTS16 ADAMTS18 MMP16	2.52e-04	43	134	4	IPR001818
Domain	PSI	ITGB6 PLXNC1 SEMA3B SEMA3E	2.75e-04	44	134	4	IPR016201
Domain	-	ADAMTS12 TLL2 ADAMTS16 ADAMTS18 MMP16	2.92e-04	81	134	5	3.40.390.10
Domain	MetalloPept_cat_dom	ADAMTS12 TLL2 ADAMTS16 ADAMTS18 MMP16	2.92e-04	81	134	5	IPR024079
Domain	PLAC	ADAMTS12 ADAMTS16 ADAMTS18	3.22e-04	19	134	3	PS50900
Domain	PLAC	ADAMTS12 ADAMTS16 ADAMTS18	3.22e-04	19	134	3	IPR010909
Domain	PSI	ITGB6 PLXNC1 SEMA3B SEMA3E	3.27e-04	46	134	4	SM00423
Domain	SPRY	TRIM39 RYR1 RYR3 BTN1A1 HERC1	4.07e-04	87	134	5	SM00449
Domain	Mab-21-like_1/2	MAB21L2 MAB21L1	5.04e-04	5	134	2	IPR020950
Domain	ADAM_spacer1	ADAMTS12 ADAMTS16 ADAMTS18	5.76e-04	23	134	3	IPR010294
Domain	ADAM_spacer1	ADAMTS12 ADAMTS16 ADAMTS18	5.76e-04	23	134	3	PF05986
Domain	SPRY	TRIM39 RYR1 RYR3 BTN1A1 HERC1	5.81e-04	94	134	5	PF00622
Domain	SPRY_dom	TRIM39 RYR1 RYR3 BTN1A1 HERC1	5.81e-04	94	134	5	IPR003877
Domain	B30.2/SPRY	TRIM39 RYR1 RYR3 BTN1A1 HERC1	6.10e-04	95	134	5	IPR001870
Domain	B302_SPRY	TRIM39 RYR1 RYR3 BTN1A1 HERC1	6.10e-04	95	134	5	PS50188
Domain	Peptidase_M12B_ADAM-TS	ADAMTS12 ADAMTS16 ADAMTS18	6.55e-04	24	134	3	IPR013273
Domain	ZINC_PROTEASE	ADAMTS12 TLL2 ADAMTS16 ADAMTS18 MMP16	7.02e-04	98	134	5	PS00142
Domain	RIH_assoc-dom	RYR1 RYR3	7.52e-04	6	134	2	IPR013662
Domain	Ins145_P3_rec	RYR1 RYR3	7.52e-04	6	134	2	PF08709
Domain	RIH_assoc	RYR1 RYR3	7.52e-04	6	134	2	PF08454
Domain	RIH_dom	RYR1 RYR3	7.52e-04	6	134	2	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR3	7.52e-04	6	134	2	IPR014821
Domain	Ryanodine_recept-rel	RYR1 RYR3	7.52e-04	6	134	2	IPR015925
Domain	-	RYR1 RYR3	7.52e-04	6	134	2	1.25.10.30
Domain	RYDR_ITPR	RYR1 RYR3	7.52e-04	6	134	2	PF01365
Domain	Laminin_G	LAMA3 FAT1 COL14A1 USH2A	7.96e-04	58	134	4	IPR001791
Domain	TSP_1	THSD7A ADAMTS12 ADAMTS16 ADAMTS18	1.09e-03	63	134	4	PF00090
Domain	TSP1	THSD7A ADAMTS12 ADAMTS16 ADAMTS18	1.22e-03	65	134	4	SM00209
Domain	TSP1_rpt	THSD7A ADAMTS12 ADAMTS16 ADAMTS18	1.22e-03	65	134	4	IPR000884
Domain	TSP1	THSD7A ADAMTS12 ADAMTS16 ADAMTS18	1.22e-03	65	134	4	PS50092
Domain	Semap_dom	PLXNC1 SEMA3B SEMA3E	1.40e-03	31	134	3	IPR001627
Domain	SEMA	PLXNC1 SEMA3B SEMA3E	1.40e-03	31	134	3	PS51004
Domain	Sema	PLXNC1 SEMA3B SEMA3E	1.40e-03	31	134	3	SM00630
Domain	Sema	PLXNC1 SEMA3B SEMA3E	1.40e-03	31	134	3	PF01403
Domain	-	VWF ITGB6 SEC24C COL14A1	1.98e-03	74	134	4	3.40.50.410
Domain	MIR	RYR1 RYR3	2.21e-03	10	134	2	PF02815
Domain	MIR_motif	RYR1 RYR3	2.21e-03	10	134	2	IPR016093
Domain	MIR	RYR1 RYR3	2.21e-03	10	134	2	PS50919
Domain	MIR	RYR1 RYR3	2.21e-03	10	134	2	SM00472
Domain	EGF_1	LAMA3 ITGB6 FAT1 UMODL1 TLL2 LRP1 USH2A	2.46e-03	255	134	7	PS00022
Domain	LAM_G_DOMAIN	LAMA3 FAT1 USH2A	2.54e-03	38	134	3	PS50025
Domain	Pep_M12B_propep	ADAMTS12 ADAMTS16 ADAMTS18	2.73e-03	39	134	3	PF01562
Domain	Peptidase_M12B_N	ADAMTS12 ADAMTS16 ADAMTS18	2.73e-03	39	134	3	IPR002870
Domain	DISINTEGRIN_1	ADAMTS12 ADAMTS16 ADAMTS18	2.94e-03	40	134	3	PS00427
Domain	Reprolysin	ADAMTS12 ADAMTS16 ADAMTS18	2.94e-03	40	134	3	PF01421
Domain	Laminin_G_2	LAMA3 FAT1 USH2A	2.94e-03	40	134	3	PF02210
Domain	ADAM_MEPRO	ADAMTS12 ADAMTS16 ADAMTS18	2.94e-03	40	134	3	PS50215
Domain	DISINTEGRIN_2	ADAMTS12 ADAMTS16 ADAMTS18	2.94e-03	40	134	3	PS50214
Domain	Peptidase_M12B	ADAMTS12 ADAMTS16 ADAMTS18	2.94e-03	40	134	3	IPR001590
Domain	Disintegrin_dom	ADAMTS12 ADAMTS16 ADAMTS18	3.15e-03	41	134	3	IPR001762
Domain	Mab-21	MAB21L2 MAB21L1	3.22e-03	12	134	2	PF03281
Domain	Mab-21	MAB21L2 MAB21L1	3.22e-03	12	134	2	SM01265
Domain	Mab-21_dom	MAB21L2 MAB21L1	3.22e-03	12	134	2	IPR024810
Domain	EGF_CA	FAT1 UMODL1 TLL2 LRP1	3.42e-03	86	134	4	PF07645
Domain	LamG	LAMA3 FAT1 USH2A	3.86e-03	44	134	3	SM00282
Domain	PLAC	ADAMTS16 ADAMTS18	4.39e-03	14	134	2	PF08686
Domain	EGF_Ca-bd_CS	FAT1 UMODL1 TLL2 LRP1	5.25e-03	97	134	4	IPR018097
Domain	EGF_CA	FAT1 UMODL1 TLL2 LRP1	5.64e-03	99	134	4	PS01187
Domain	VWF_A	VWF ITGB6 SEC24C COL14A1	5.64e-03	99	134	4	IPR002035
Domain	Laminin_N	LAMA3 USH2A	5.74e-03	16	134	2	IPR008211
Domain	LamNT	LAMA3 USH2A	5.74e-03	16	134	2	SM00136
Domain	LAMININ_NTER	LAMA3 USH2A	5.74e-03	16	134	2	PS51117
Domain	Laminin_N	LAMA3 USH2A	5.74e-03	16	134	2	PF00055
Domain	EGF-type_Asp/Asn_hydroxyl_site	FAT1 UMODL1 TLL2 LRP1	7.16e-03	106	134	4	IPR000152
Pathway	WP_FATTY_ACID_OMEGAOXIDATION	CYP1A1 CYP1A2 ADH7	5.33e-05	10	110	3	MM15833
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	LAMA3 TLL2 ADAMTS16 ADAMTS18 COL14A1 MMP16 KLKB1	1.11e-04	140	110	7	M587
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	VWF LAMA3 ITGB6 TLL2 ADAMTS16 ADAMTS18 FGF2 COL14A1 MMP16 KLKB1	1.18e-04	300	110	10	M610
Pathway	WP_FATTY_ACID_OMEGAOXIDATION	CYP1A1 CYP1A2 ADH7	1.96e-04	15	110	3	M39717
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	THSD7A ADAMTS12 ADAMTS16 ADAMTS18	2.34e-04	39	110	4	M27417
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	THSD7A ADAMTS12 ADAMTS16 ADAMTS18	2.34e-04	39	110	4	MM15165
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	MTIF3 NAALAD2 MYCBP2 OTUD5 IREB2 MRPS18C FREM2 FAT1 RABL2A TRANK1 MAP4K5 FGF2 PRMT1 COL14A1 FBLIM1 PC KLKB1 TRIM37 AGTPBP1 CDCA4	6.74e-08	1215	137	20	15146197
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TLK2 ZNF148 MYCBP2 OTUD5 ESRRA PALB2 MSH6 MYOF SEC24C SAFB2 UTP20 DDX21 ANAPC5 TP53BP1 AGTPBP1 USP47	7.54e-08	774	137	16	15302935
Pubmed	Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.	RYR1 RYR3 ATP2A1	2.38e-07	4	137	3	9384575
Pubmed	Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells.	RYR1 RYR3 PRKCE	5.95e-07	5	137	3	19011160
Pubmed	Type 3 and type 1 ryanodine receptors are localized in triads of the same mammalian skeletal muscle fibers.	RYR1 RYR3 ATP2A1	1.19e-06	6	137	3	10444070
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYCBP2 MTHFD1L ANXA6 CSDE1 MSH6 SEC24C ATAD2B UTP20 ZNF512 DDX21 RPL10 TP53BP1 USP47	2.04e-06	653	137	13	22586326
Pubmed	Sequential docking, molecular differentiation, and positioning of T-Tubule/SR junctions in developing mouse skeletal muscle.	RYR1 RYR3 ATP2A1	3.30e-06	8	137	3	11784029
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	RYR1 RYR3 ATP2A1	3.30e-06	8	137	3	19033399
Pubmed	Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.	CYP1A1 CYP1A2 PGR	4.94e-06	9	137	3	16985250
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MYCBP2 MTHFD1L PKP4 GARS1 CSDE1 MSH6 NAA35 SEC24C MAP4K5 SAFB2 UTP20 PRMT1 POLR1B DDX60L ZNF512 DDX21 ALOX12B TP53BP1	6.53e-06	1353	137	18	29467282
Pubmed	Polymorphisms in phase I and phase II metabolism genes and risk of chronic benzene poisoning in a Chinese occupational population.	CYP1A1 CYP1A2 UGT1A6	7.03e-06	10	137	3	18784359
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	TRPM7 RYR1 RYR3 ATP2A1	1.53e-05	38	137	4	30786075
Pubmed	PRMT1, a Key Modulator of Unliganded Progesterone Receptor Signaling in Breast Cancer.	PGR PRMT1	1.54e-05	2	137	2	36076907
Pubmed	Methylation differences in the murine P1450 and P3450 genes in wild-type and mutant hepatoma cell culture.	CYP1A1 CYP1A2	1.54e-05	2	137	2	2425809
Pubmed	Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6.	CYP1A1 CYP1A2	1.54e-05	2	137	2	3000715
Pubmed	RABL2 Is Required for Hepatic Fatty Acid Homeostasis and Its Dysfunction Leads to Steatosis and a Diabetes-Like State.	RABL2B RABL2A	1.54e-05	2	137	2	27732084
Pubmed	Characterization of human CYP1A1/1A2 induction by DNA microarray and alpha-naphthoflavone.	CYP1A1 CYP1A2	1.54e-05	2	137	2	12147246
Pubmed	Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS.	CYP1A1 CYP1A2	1.54e-05	2	137	2	17852022
Pubmed	Cyp1a2 protects against reactive oxygen production in mouse liver microsomes.	CYP1A1 CYP1A2	1.54e-05	2	137	2	14980704
Pubmed	Protein kinase C epsilon affects mitochondrial function through estrogen-related receptor alpha.	ESRRA PRKCE	1.54e-05	2	137	2	21596133
Pubmed	Contractile impairment and structural alterations of skeletal muscles from knockout mice lacking type 1 and type 3 ryanodine receptors.	RYR1 RYR3	1.54e-05	2	137	2	9489997
Pubmed	Immunocytochemical study of cytochrome P450 (1A1/1A2) induction in murine ocular tissues.	CYP1A1 CYP1A2	1.54e-05	2	137	2	7781742
Pubmed	Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation.	CYP1A1 CYP1A2	1.54e-05	2	137	2	11207026
Pubmed	The block of ryanodine receptors selectively inhibits fetal myoblast differentiation.	RYR1 RYR3	1.54e-05	2	137	2	12640042
Pubmed	Cerebellar mutations affecting the postnatal survival of Purkinje cells in the mouse disclose a longitudinal pattern of differentially sensitive cells.	HERC1 AGTPBP1	1.54e-05	2	137	2	3678603
Pubmed	Tissue-specific expression of the mouse dioxin-inducible P(1)450 and P(3)450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues.	CYP1A1 CYP1A2	1.54e-05	2	137	2	3785172
Pubmed	Assignment of dioxin-inducible cytochrome P-450 gene family to Chinese hamster chromosome 4.	CYP1A1 CYP1A2	1.54e-05	2	137	2	3860967
Pubmed	Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype.	CYP1A1 CYP1A2	1.54e-05	2	137	2	16609368
Pubmed	Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria.	CYP1A1 CYP1A2	1.54e-05	2	137	2	15094312
Pubmed	Possible involvement of ryanodine receptor-mediated intracellular calcium release in the effect of corticotropin-releasing factor on adrenocorticotropin secretion.	RYR1 RYR3	1.54e-05	2	137	2	14592949
Pubmed	Analysis of relative gene dosage and expression differences of the paralogs RABL2A and RABL2B by Pyrosequencing.	RABL2B RABL2A	1.54e-05	2	137	2	20138207
Pubmed	CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines.	CYP1A1 CYP1A2	1.54e-05	2	137	2	19285097
Pubmed	TRIM37 controls cancer-specific vulnerability to PLK4 inhibition.	PLK4 TRIM37	1.54e-05	2	137	2	32908304
Pubmed	[Association of polymorph variants of CYP1A2 and CYP1A1 genes with reproductive and thyroid diseases in female workers of petrochemical industry].	CYP1A1 CYP1A2	1.54e-05	2	137	2	22855999
Pubmed	Differential regulation of expression of hepatic and pulmonary cytochrome P4501A enzymes by 3-methylcholanthrene in mice lacking the CYP1A2 gene.	CYP1A1 CYP1A2	1.54e-05	2	137	2	12438513
Pubmed	von Willebrand Factor and Prekallikrein in Plasma Are Associated With Thrombus Volume in Abdominal Aortic Aneurysms.	VWF KLKB1	1.54e-05	2	137	2	27581227
Pubmed	Morphological abnormalities of adrenal gland and hypertrophy of liver in mutant mice lacking ryanodine receptors.	RYR1 RYR3	1.54e-05	2	137	2	9799464
Pubmed	Induction of cytochromes P450 1A1 and 1A2 by tanshinones in human HepG2 hepatoma cell line.	CYP1A1 CYP1A2	1.54e-05	2	137	2	21262253
Pubmed	Epidermal Growth Factor Receptor Kinase Inhibitors Synergize with TCDD to Induce CYP1A1/1A2 in Human Breast Epithelial MCF10A Cells.	CYP1A1 CYP1A2	1.54e-05	2	137	2	26953171
Pubmed	Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition.	CYP1A1 CYP1A2	1.54e-05	2	137	2	18493746
Pubmed	53BP1 oligomerization is independent of its methylation by PRMT1.	PRMT1 TP53BP1	1.54e-05	2	137	2	16294047
Pubmed	The GAR motif of 53BP1 is arginine methylated by PRMT1 and is necessary for 53BP1 DNA binding activity.	PRMT1 TP53BP1	1.54e-05	2	137	2	16294045
Pubmed	Polycyclic Aromatic Hydrocarbon-induced Pulmonary Carcinogenesis in Cytochrome P450 (CYP)1A1- and 1A2-Null Mice: Roles of CYP1A1 and CYP1A2.	CYP1A1 CYP1A2	1.54e-05	2	137	2	32726451
Pubmed	A shuffled CYP1A library shows both structural integrity and functional diversity.	CYP1A1 CYP1A2	1.54e-05	2	137	2	17823232
Pubmed	Depletion of Mab21l1 and Mab21l2 messages in mouse embryo arrests axial turning, and impairs notochord and neural tube differentiation.	MAB21L2 MAB21L1	1.54e-05	2	137	2	11857508
Pubmed	Comparison of the flanking regions and introns of the mouse 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 and P3-450 genes.	CYP1A1 CYP1A2	1.54e-05	2	137	2	3988744
Pubmed	CYP1A1 and CYP1A2 expression levels are differentially regulated in three-dimensional spheroids of liver cancer cells compared to two-dimensional monolayer cultures.	CYP1A1 CYP1A2	1.54e-05	2	137	2	26643992
Pubmed	Preferred binding orientations of phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism.	CYP1A1 CYP1A2	1.54e-05	2	137	2	22949628
Pubmed	Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development.	RYR1 RYR3	1.54e-05	2	137	2	17118445
Pubmed	Biochemical analysis of the arginine methylation of high molecular weight fibroblast growth factor-2.	FGF2 PRMT1	1.54e-05	2	137	2	10652299
Pubmed	Increased basal expression of hepatic Cyp1a1 and Cyp1a2 genes in inbred mice selected for susceptibility to acetaminophen-induced hepatotoxicity.	CYP1A1 CYP1A2	1.54e-05	2	137	2	9295056
Pubmed	RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle.	RYR1 RYR3	1.54e-05	2	137	2	11500519
Pubmed	Disruption of cytochrome P4501A2 in mice leads to increased susceptibility to hyperoxic lung injury.	CYP1A1 CYP1A2	1.54e-05	2	137	2	25680282
Pubmed	Uterine Dnmt3a is not Required for Mouse Embryo Implantation.	PGR DNMT3A	1.54e-05	2	137	2	32096741
Pubmed	Sex-specific differences in hyperoxic lung injury in mice: role of cytochrome P450 (CYP)1A.	CYP1A1 CYP1A2	1.54e-05	2	137	2	25703676
Pubmed	Developmental and tissue-specific differential regulation of the mouse dioxin-inducible P1-450 and P3-450 genes.	CYP1A1 CYP1A2	1.54e-05	2	137	2	4054433
Pubmed	Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice.	CYP1A1 CYP1A2	1.54e-05	2	137	2	31147315
Pubmed	Aryl hydrocarbon (Ah) receptor-independent induction of Cyp1a2 gene expression by acenaphthylene and related compounds in B6C3F1 mice.	CYP1A1 CYP1A2	1.54e-05	2	137	2	8001243
Pubmed	Metabolism of 4-n-nonylphenol by non-modified and CYP1A1- and CYP1A2-transgenic cell cultures of tobacco.	CYP1A1 CYP1A2	1.54e-05	2	137	2	16402549
Pubmed	The effect of CYP1A1 and CYP1A2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.	CYP1A1 CYP1A2	1.54e-05	2	137	2	24443269
Pubmed	The Male Abnormal Gene Family 21 (Mab21) Members Regulate Eye Development.	MAB21L2 MAB21L1	1.54e-05	2	137	2	27558071
Pubmed	Preferential inducibility of CYP1A1 and CYP1A2 by TCDD: differential regulation in primary human hepatocytes versus transformed human cells.	CYP1A1 CYP1A2	1.54e-05	2	137	2	16426572
Pubmed	Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene.	RYR1 RYR3	1.54e-05	2	137	2	12565913
Pubmed	The influence of CYP1A1 and CYP1A2 polymorphisms on stroke risk in the Chinese population.	CYP1A1 CYP1A2	1.54e-05	2	137	2	33046100
Pubmed	Functional and morphological features of skeletal muscle from mutant mice lacking both type 1 and type 3 ryanodine receptors.	RYR1 RYR3	1.54e-05	2	137	2	9192302
Pubmed	CYP1A1/2 haplotypes and lung cancer and assessment of confounding by population stratification.	CYP1A1 CYP1A2	1.54e-05	2	137	2	19276377
Pubmed	Isolation and partial cloning of ryanodine-sensitive Ca2+ release channel protein isoforms from human myometrial smooth muscle.	RYR1 RYR3	1.54e-05	2	137	2	7556644
Pubmed	Mouse lung CYP1A1 catalyzes the metabolic activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).	CYP1A1 CYP1A2	1.54e-05	2	137	2	17052995
Pubmed	Differences in regulation of gene expression between Cyp1a-1 and Cyp1a-2 in adult mouse hepatocytes in primary culture.	CYP1A1 CYP1A2	1.54e-05	2	137	2	1335375
Pubmed	Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.	CYP1A1 CYP1A2	1.54e-05	2	137	2	8095225
Pubmed	Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction.	RYR1 RYR3	1.54e-05	2	137	2	15894801
Pubmed	Two novel human RAB genes with near identical sequence each map to a telomere-associated region: the subtelomeric region of 22q13.3 and the ancestral telomere band 2q13.	RABL2B RABL2A	1.54e-05	2	137	2	10444334
Pubmed	A common regulatory region functions bidirectionally in transcriptional activation of the human CYP1A1 and CYP1A2 genes.	CYP1A1 CYP1A2	1.54e-05	2	137	2	16505155
Pubmed	Genomic cloning and chromosomal localization of the mouse Mab21l2 locus.	MAB21L2 MAB21L1	1.54e-05	2	137	2	10516425
Pubmed	Variants in RABL2A causing male infertility and ciliopathy.	RABL2B RABL2A	1.54e-05	2	137	2	33075816
Pubmed	Enzyme-kinetic and immunochemical characteristics of mouse cDNA-expressed, microsomal, and purified CYP1A1 and CYP1A2.	CYP1A1 CYP1A2	1.54e-05	2	137	2	8274012
Pubmed	Species difference among experimental rodents in induction of P450IA family enzymes by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.	CYP1A1 CYP1A2	1.54e-05	2	137	2	1452456
Pubmed	Amino-terminal sequence and structure of monoclonal antibody immunopurified cytochromes P-450.	CYP1A1 CYP1A2	1.54e-05	2	137	2	3718958
Pubmed	Balancer-Cre transgenic mouse germ cells direct the incomplete resolution of a tri-loxP-targeted Cyp1a1 allele, producing a conditional knockout allele.	CYP1A1 CYP1A2	1.54e-05	2	137	2	14637164
Pubmed	Effect of calmodulin on Ca2+-induced Ca2+ release of skeletal muscle from mutant mice expressing either ryanodine receptor type 1 or type 3.	RYR1 RYR3	1.54e-05	2	137	2	9817784
Pubmed	Comparison of mouse hepatic mitochondrial versus microsomal cytochromes P450 following TCDD treatment.	CYP1A1 CYP1A2	1.54e-05	2	137	2	16516144
Pubmed	Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date.	CYP1A1 CYP1A2	1.54e-05	2	137	2	28698457
Pubmed	[Association of cytochrome P450 genes polymorphisms (CYP1A1 and CYP1A2) with the development of chronic obstructive pulmonary disease in Bashkortostan].	CYP1A1 CYP1A2	1.54e-05	2	137	2	18389617
Pubmed	Evaluation of ADAMTS12, ADAMTS16, ADAMTS18 and IL-33 serum levels in pre-eclampsia.	ADAMTS16 ADAMTS18	1.54e-05	2	137	2	26382559
Pubmed	Isolation and characterization of full-length mouse cDNA and genomic clones of 3-methylcholanthrene-inducible cytochrome P1-450 and P3-450.	CYP1A1 CYP1A2	1.54e-05	2	137	2	6548461
Pubmed	Molecular mechanisms of pulmonary carcinogenesis by polycyclic aromatic hydrocarbons (PAHs): Implications for human lung cancer.	CYP1A1 CYP1A2	1.54e-05	2	137	2	34242741
Pubmed	RABL2 positively controls localization of GPCRs in mammalian primary cilia.	RABL2B RABL2A	1.54e-05	2	137	2	30578315
Pubmed	Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery.	CYP1A1 CYP1A2	1.54e-05	2	137	2	10623596
Pubmed	Rapid induction of colon carcinogenesis in CYP1A-humanized mice by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate.	CYP1A1 CYP1A2	1.54e-05	2	137	2	21081470
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF704 AMD1 TUT4 MYCBP2 ANXA6 LAMA3 CSDE1 PTPRB SEMA3B LRP1 PRKCE PLA2G6 SERINC5 PRORP MED27 ZNF512 MMP16 SMYD3	2.36e-05	1489	137	18	28611215
Pubmed	Genetic variation of genes for xenobiotic-metabolizing enzymes and risk of bronchial asthma: the importance of gene-gene and gene-environment interactions for disease susceptibility.	CYP1A1 CYP1A2 UGT1A6	2.63e-05	15	137	3	19575027
Pubmed	Microarray analysis of Foxa2 mutant mouse embryos reveals novel gene expression and inductive roles for the gastrula organizer and its derivatives.	PABPC4L SLC10A3 CWC22 RABL2B RABL2A PRMT1 FBLIM1 PREX1	3.07e-05	306	137	8	18973680
Pubmed	Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.	CYP1A1 CYP1A2 PGR	3.23e-05	16	137	3	19415745
Pubmed	ADAMTS18 Deficiency Affects Neuronal Morphogenesis and Reduces the Levels of Depression-like Behaviors in Mice.	LAMA3 ADAMTS16 ADAMTS18	3.23e-05	16	137	3	30579834
Pubmed	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	ANXA6 CWC22 CSDE1 MSH6 SEC24C SAFB2 PRMT1 DDX21	3.77e-05	315	137	8	26777405
Pubmed	Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk.	CYP1A1 CYP1A2 PGR	3.90e-05	17	137	3	20381444
Pubmed	Semaphorin signaling facilitates cleft formation in the developing salivary gland.	PLXNC1 SEMA3B SEMA3E	3.90e-05	17	137	3	17626059
Pubmed	Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.	CYP1A1 CYP1A2 UGT1A6	3.90e-05	17	137	3	19424794
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR3	4.61e-05	3	137	2	18403125
Pubmed	Characterization and mapping of the 12 kDa FK506-binding protein (FKBP12)-binding site on different isoforms of the ryanodine receptor and of the inositol 1,4,5-trisphosphate receptor.	RYR1 RYR3	4.61e-05	3	137	2	11171121
Cytoband	Ensembl 112 genes in cytogenetic band chr4q28	PABPC4L FGF2 PLK4 SLC25A31	1.06e-04	81	137	4	chr4q28
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR3	8.34e-05	3	96	2	287
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS12 ADAMTS16 ADAMTS18	1.32e-04	19	96	3	50
GeneFamily	Cytochrome P450 family 1	CYP1A1 CYP1A2	1.66e-04	4	96	2	1000
GeneFamily	RAB like GTPases	RABL2B RABL2A	2.76e-04	5	96	2	394
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TLK2 TUT4 ZNF148 AUH MYCBP2 PKP4 MSH6 MYOF FAT1 ZFYVE9 MAP4K5 ATAD2B FGF2 UTP20 DDX21 TRIM37 TP53BP1	2.27e-06	856	136	17	M4500
Coexpression	GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP	ATAD5 PPM1J NAA35 SEC24C PLXNC1 UTP20 TAF1 AGTPBP1	4.72e-06	180	136	8	M8127
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	TLK2 TUT4 ZNF148 AUH MYCBP2 PKP4 FAT1 ZFYVE9 MAP4K5 ATAD2B FGF2 TRIM37	6.00e-06	466	136	12	M13522
Coexpression	REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	VWF PKP4 RYR1 PLXNC1 ATP2A1 MAB21L1	1.32e-05	99	136	6	M768
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	AMD1 PHLDA1 MTHFD1L PGR MYOF SEMA3B POLR1B DDX21	2.63e-05	228	136	8	M2151
Coexpression	GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP	ACADVL ESRRA GTF2E1 MAP4K5 ATAD2B PRMT1 PC	7.60e-05	196	136	7	M5256
Coexpression	GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP	TUT4 VWF ANXA6 PLXNC1 HERC1 ATP2A1 TP53BP1	8.10e-05	198	136	7	M4639
Coexpression	SANA_TNF_SIGNALING_DN	VWF THSD7A PHLDA1 PGAM2 MYOF	8.21e-05	85	136	5	M19467
Coexpression	GSE27786_BCELL_VS_CD8_TCELL_DN	VWF MYCBP2 MTHFD1L PPM1J SEMA3B FBLIM1 DDX21	8.36e-05	199	136	7	M4802
Coexpression	GSE3982_MAST_CELL_VS_MAC_UP	MED20 SLC10A3 ZFYVE9 UTP20 HERC1 SMYD3 SEMA3E	8.36e-05	199	136	7	M5429
Coexpression	HALLMARK_MYOGENESIS	TEAD4 PGAM2 RYR1 FGF2 SPDEF PC ATP2A1	8.63e-05	200	136	7	M5909
Coexpression	GSE17721_12H_VS_24H_POLYIC_BMDC_UP	PHLDA1 DOCK8 CAMP ANXA6 SLC10A3 FGF2 ATP2A1	8.63e-05	200	136	7	M4101
Coexpression	NABA_MATRISOME	VWF ANXA6 LAMA3 ADAMTS12 S100A10 FREM2 PLXNC1 TLL2 SEMA3B ADAMTS16 ADAMTS18 FGF2 COL14A1 MMP16 USH2A SEMA3E	8.68e-05	1026	136	16	M5889
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	TLK2 NAALAD2 TUT4 ZNF148 TRPM7 ANXA6 PKP4 PABPC4L NAA35 ZC3HAV1L LRP1 PRMT1 DDX3Y HERC1 FBLIM1 MMP16 ANAPC5 SLC25A31 SEMA3E DNMT3A	1.93e-07	801	136	20	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	TLK2 NAALAD2 ZNF148 TRPM7 ANXA6 PKP4 PABPC4L ADAMTS16 LRP1 DDX3Y HERC1 FBLIM1 MMP16 ANAPC5	3.58e-07	406	136	14	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	TLK2 NAALAD2 ZNF148 TRPM7 ANXA6 PKP4 PABPC4L LRP1 DDX3Y HERC1 FBLIM1 MMP16 SLC25A31 DNMT3A	4.39e-07	413	136	14	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500	TLK2 ZNF148 TRPM7 PKP4 PABPC4L NAA35 PLXNC1 ADAMTS16 PRMT1 DDX3Y HERC1 FBLIM1 SLC25A31	2.01e-06	403	136	13	gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_500	TRANK1 PLXNC1 ADAMTS16 DDX3Y COL14A1 SERINC5	5.32e-06	69	136	6	gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000	PGAM2 FAT1 TRANK1 PLXNC1 ADAMTS16 DDX3Y COL14A1 SERINC5	7.19e-06	155	136	8	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k1_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500	TLK2 NAALAD2 ZNF148 TRPM7 ANXA6 PKP4 ADAMTS16 DDX3Y COL14A1 HERC1 FBLIM1 MMP16	1.16e-05	404	136	12	gudmap_developingGonad_e18.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	TLK2 NAALAD2 ZNF148 TRPM7 ANXA6 PKP4 PABPC4L ZC3HAV1L ADAMTS16 LRP1 DDX3Y COL14A1 HERC1 FBLIM1 MMP16 ANAPC5 DNMT3A	1.24e-05	790	136	17	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	TLK2 ZNF148 TRPM7 ANXA6 PKP4 PABPC4L NAA35 PLXNC1 ADAMTS16 PRMT1 DDX3Y HERC1 FBLIM1 MMP16 ANAPC5 SLC25A31 DNMT3A	1.60e-05	806	136	17	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	TLK2 TUT4 VWF ZNF148 TRPM7 ANXA6 PKP4 PABPC4L NAA35 ADAMTS18 PRMT1 HERC1 FBLIM1 MMP16 ANAPC5 SLC25A31 DNMT3A	1.85e-05	815	136	17	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	NAALAD2 TUT4 ATAD5 ANXA6 PABPC4L MYOF FAT1 TRANK1 PLXNC1 LRP1 DDX3Y COL14A1 SERINC5 FBLIM1 MMP16 DNMT3A	3.64e-05	773	136	16	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_1000	PHLDA1 DOCK8 STK17B ANXA6 LAMA3 RYR3 ADH7 S100A10 FREM2 MYOF PTPRB DDX3Y PRKCE COL14A1 GRHL3 SEMA3E	3.69e-05	774	136	16	gudmap_developingLowerUrinaryTract_P1_bladder_1000_B
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_500	FAT1 TRANK1 PLXNC1 ADAMTS16 COL14A1 SERINC5	4.01e-05	98	136	6	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500	TLK2 ZNF148 ANXA6 PKP4 NAA35 PLXNC1 ADAMTS16 DDX3Y CXorf58 HERC1 SLC25A31	4.07e-05	387	136	11	gudmap_developingGonad_e16.5_ovary_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	TLK2 ZNF148 TRPM7 ANXA6 PKP4 RYR1 NAA35 PLXNC1 ADAMTS16 DDX3Y CXorf58 HERC1 MMP16 ANAPC5 SLC25A31 DNMT3A	5.08e-05	795	136	16	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	TLK2 NAALAD2 ZNF148 TRPM7 ANXA6 PKP4 PABPC4L ADAMTS16 LRP1 DDX3Y COL14A1 HERC1 FBLIM1 MMP16 ANAPC5 DNMT3A	5.39e-05	799	136	16	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500	TRANK1 PLXNC1 ADAMTS16 COL14A1 SERINC5	9.93e-05	72	136	5	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k1_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500	PABPC4L MYOF FAT1 TRANK1 PLXNC1 ADAMTS16 LRP1 DDX3Y COL14A1 SERINC5	1.22e-04	364	136	10	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	TUT4 ATAD5 ANXA6 PABPC4L MYOF FAT1 TRANK1 PLXNC1 ADAMTS16 LRP1 DDX3Y COL14A1 SERINC5 FBLIM1 DNMT3A	1.23e-04	768	136	15	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000	TLK2 NAALAD2 ZNF148 ANXA6 PKP4 PABPC4L ADAMTS16 LRP1 DDX3Y COL14A1 HERC1 FBLIM1 MMP16 ANAPC5 DNMT3A	1.84e-04	797	136	15	gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000	ZNF148 ANXA6 NAA35 LRP1 DDX3Y FBLIM1 ANAPC5	1.87e-04	184	136	7	gudmap_developingGonad_e14.5_ epididymis_1000_k2
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#2_top-relative-expression-ranked_200	PLXNC1 DDX3Y COL14A1	1.95e-04	18	136	3	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k2_200
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500	TLK2 ZNF148 ANXA6 PKP4 PLXNC1 ADAMTS16 DDX3Y HERC1 MMP16 SLC25A31	2.00e-04	387	136	10	gudmap_developingGonad_e18.5_ovary_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	TLK2 ZNF148 TRPM7 ANXA6 PKP4 PABPC4L NAA35 PLXNC1 ADAMTS18 PRMT1 HERC1 MMP16 ANAPC5 SLC25A31 DNMT3A	2.03e-04	804	136	15	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000	FAT1 TRANK1 PLXNC1 ADAMTS16 DDX3Y COL14A1 SERINC5	2.35e-04	191	136	7	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k4_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000	FAT1 TRANK1 PLXNC1 DDX3Y COL14A1 SERINC5	2.66e-04	138	136	6	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_1000
CoexpressionAtlas	dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#3_top-relative-expression-ranked_100	TRANK1 PLXNC1 ADAMTS16	2.70e-04	20	136	3	gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k3_100
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	KLHL6 MED20 PABPC4L ADAMTS12 MYOF TRANK1 PLXNC1 LRP1 DDX3Y COL14A1 SERINC5 FBLIM1 MMP16 SEMA3E DNMT3A	2.74e-04	827	136	15	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000	KLHL6 PHLDA1 STK17B CWC22 ADAMTS12 MYOF TRANK1 PLXNC1 ADAMTS16 LRP1 DDX3Y COL14A1 SERINC5 FBLIM1 SEMA3E	3.62e-04	849	136	15	gudmap_dev gonad_e11.5_M_GonMes_Sma_1000
CoexpressionAtlas	ECTO blastocyst_vs_ECTO amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05	DOCK8 CLDN7 MAB21L2 NLRP2 S100A10 FREM2 COL14A1 PREX1	4.54e-04	280	136	8	PCBC_ratio_ECTO blastocyst_vs_ECTO amniotic fluid MSC_cfr-2X-p05
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	TLK2 TRPM7 ANXA6 PKP4 PABPC4L LRP1 MMP16 DNMT3A	4.65e-04	281	136	8	gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	TLK2 ZNF148 STK17B ANXA6 PKP4 PABPC4L PALB2 NAA35 ADAMTS16 DDX3Y CXorf58 HERC1 MMP16 SLC25A31	4.66e-04	776	136	14	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	TLK2 ZNF148 TRPM7 ANXA6 PKP4 PABPC4L NAA35 PLXNC1 ADAMTS16 DDX3Y CXorf58 HERC1 MMP16 SLC25A31	4.78e-04	778	136	14	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	ECTO blastocyst_vs_ECTO UCB CD34+Z-Confounder_removed-fold2.0_adjp0.05	PHLDA1 DOCK8 MAB21L2 NLRP2 S100A10 FREM2 SEMA3B PREX1	4.99e-04	284	136	8	PCBC_ratio_ECTO blastocyst_vs_ECTO UCB CD34+Z_cfr-2X-p05
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000	VWF ZNF148 NAA35 PRMT1 FBLIM1 ANAPC5	5.12e-04	156	136	6	gudmap_developingGonad_e11.5_ovary + mesonephros_k4_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_1000	TRANK1 PLXNC1 ADAMTS16 DDX3Y COL14A1 SERINC5	5.12e-04	156	136	6	gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_100	TRANK1 PLXNC1 COL14A1	5.33e-04	25	136	3	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_100
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_1000	TRANK1 PLXNC1 DDX3Y COL14A1 SERINC5	5.54e-04	104	136	5	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	PABPC4L CWC22 PGAM2 MYOF FAT1 TRANK1 PLXNC1 ADAMTS16 LRP1 DDX3Y COL14A1 SERINC5 FBLIM1 DNMT3A	5.76e-04	793	136	14	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	gudmap_RNAseq_e15.5_Mesangium_2500_K4	PHLDA1 UGT1A6 CLDN7 ITGB6 S100A10 ADAMTS18	6.24e-04	162	136	6	gudmap_RNAseq_e15.5_Mesangium_2500_K4
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	CWC22 MYOF TRANK1 PLXNC1 ADAMTS16 LRP1 DDX3Y COL14A1 SERINC5	6.83e-04	373	136	9	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500
CoexpressionAtlas	DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000	ZNF148 ANXA6 LAMA3 S100A10 NAA35 TRANK1 PLXNC1 SAFB2 PRMT1 DDX3Y FBLIM1 PC ANAPC5 SLC25A31	7.44e-04	814	136	14	gudmap_developingGonad_e18.5_testes_1000
ToppCell	Adult-Endothelial-endothelial_cell_of_artery\|Adult / Lineage, Cell type, age group and donor	VWF THSD7A RYR3 PTPRB FGF2 FGD5 FBLIM1 MMP16	1.16e-07	186	137	8	2d1c4ea2e401db89971582ee54618a8b0c81b8ac
ToppCell	P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KLHL6 CYP1A1 VWF S100A10 PTPRB ADAMTS18 COL14A1 MMP16	1.26e-07	188	137	8	5eb107122064f0a99dfd445cc87d3766f7257216
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF THSD7A S100A10 PTPRB ADAMTS18 COL14A1 FGD5 MMP16	1.43e-07	191	137	8	0e8a73f01e3ec95d242c09231bcf3790324d0a67
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	UGT1A6 ITGB6 RYR1 ADH7 S100A10 MYOF FAT1	1.07e-06	172	137	7	e9095c3dac66cf93d31f5f88364b565abacb1e2d
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF THSD7A LAMA3 TEAD4 PALB2 PTPRB PC	1.50e-06	181	137	7	136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF THSD7A LAMA3 ADH7 MYOF PTPRB FGD5	1.56e-06	182	137	7	c7f2d24697affa530b748ab32b1d40bdc1bdc20a
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF THSD7A LAMA3 ADH7 MYOF PTPRB FGD5	1.56e-06	182	137	7	d95635b74e8cd8bc00bfe40340806b59fb9bee43
ToppCell	COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	CYP1A1 VWF THSD7A PKP4 PTPRB FGD5 MMP16	1.74e-06	185	137	7	f5e14181f45c37d13ee9e017a4c8bc248c353676
ToppCell	P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VWF THSD7A S100A10 PTPRB ADAMTS18 COL14A1 MMP16	2.08e-06	190	137	7	e1b721bb74561fe51c53328a0394c9954e489049
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELF4 CLDN7 PRAG1 ITGB6 PGR FAT1 PC	2.15e-06	191	137	7	b94e66ac71e73f46b0323d424e7b8b906751d584
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF THSD7A PTPRB ADAMTS18 COL14A1 FGD5 MMP16	2.15e-06	191	137	7	54bbccc554f43ba2ebdf9ea191b94c8f16081b53
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF THSD7A PKP4 PTPRB PRKCE FGD5 MMP16	2.30e-06	193	137	7	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF THSD7A PKP4 PTPRB PRKCE FGD5 MMP16	2.30e-06	193	137	7	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF THSD7A PKP4 PTPRB PRKCE FGD5 MMP16	2.38e-06	194	137	7	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VWF THSD7A LAMA3 PTPRB FGD5 PREX1 AGTPBP1	2.47e-06	195	137	7	d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CYP1A1 VWF THSD7A PTPRB FGF2 FBLIM1 MMP16	2.64e-06	197	137	7	ad4a3b5da2190be9495382a2952991e1de9f190d
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP1A1 VWF THSD7A TEAD4 PTPRB FGF2 FBLIM1	2.82e-06	199	137	7	6e3a226ebba023e3e909d7a7188137da4f1fd7fc
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TLK2 MYCBP2 DOCK8 STK17B ATAD2B DDX60L DDX21	2.91e-06	200	137	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP1A1 ATAD5 PTPRB ZC3HAV1L POLR1B SLC25A31	6.10e-06	146	137	6	2d907e50206c4762a8baa741363bc7f0a04bd84e
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VWF PTPRB PLXNC1 CROCC2 FGF2 FGD5	8.28e-06	154	137	6	e65e4636646164610f33f7bbac0d879a3ea55986
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PRAG1 RYR1 ADAMTS16 PREX1 ALOX12B RPL10	8.92e-06	156	137	6	2cd007b423c2395c5ce331902e7f27c805755eb3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VWF LAMA3 PABPC4L PTPRB FGD5 AGTPBP1	1.27e-05	166	137	6	8e2faca6a2e76a625de04d6098aa6f98911945c6
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF THSD7A PKP4 PTPRB ADAMTS18 MMP16	1.45e-05	170	137	6	1a568efcff9c39b3f709b55a05d24710450a2657
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VWF THSD7A PKP4 PTPRB ADAMTS18 MMP16	1.45e-05	170	137	6	66d41d794790e621d72ac37af995510537103c9c
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA3 CLDN7 ITGB6 FREM2 SEMA3B SEMA3E	1.61e-05	173	137	6	45808cf69122c16b9d2b5ffa06d15392c55954b7
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA3 CLDN7 ITGB6 FREM2 SEMA3B SEMA3E	1.61e-05	173	137	6	7fa9dbcb258c3ab974490063951620e2def03db1
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KLHL6 VWF THSD7A S100A10 PTPRB MMP16	1.71e-05	175	137	6	2e54961846c65b185d9bd6e305dd81205579d890
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA3 CLDN7 ITGB6 ADH7 PC SEMA3E	1.71e-05	175	137	6	96219e58dcb327fd27190be78193e7a0d611e62b
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D175\|Adult / Lineage, Cell type, age group and donor	VWF THSD7A PTPRB FGF2 FGD5 MMP16	1.71e-05	175	137	6	0a65ddfa8c2e8efb5b5338cf07661cb78157a23c
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LAMA3 CLDN7 ITGB6 ADH7 PC SEMA3E	1.71e-05	175	137	6	cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KLHL6 VWF THSD7A S100A10 PTPRB MMP16	1.71e-05	175	137	6	efa6a05f7417d46141b6e635f258c126b7a03aa1
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Reln_(Cortical_subplate_interneuron)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	FSIP2 BTN1A1 CXorf58 ACMSD	1.84e-05	51	137	4	73a6c4354f2f4a7de95d15467b1249f4c57b441e
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Reln_(Cortical_subplate_interneuron)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	FSIP2 BTN1A1 CXorf58 ACMSD	1.84e-05	51	137	4	650d288bd1816b3798025c9fa4cea2f6db639a55
ToppCell	facs-Lung-Endomucin-3m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1A1 VWF S100A10 PTPRB MMP16 TRIM37	1.89e-05	178	137	6	5cc182e6faa7ba5b88378d2c953be29bbbb95a7e
ToppCell	facs-Lung-Endomucin-3m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1A1 VWF S100A10 PTPRB MMP16 TRIM37	1.89e-05	178	137	6	f9a16bc3f09c35c7d30e3809da024bc2dcf746ed
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF THSD7A ACADVL LAMA3 PABPC4L PTPRB	2.01e-05	180	137	6	baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF THSD7A ACADVL LAMA3 PABPC4L PTPRB	2.01e-05	180	137	6	2d608b9394d28d19cfc85c6ac94003d5177c8a92
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF THSD7A ACADVL LAMA3 PABPC4L PTPRB	2.01e-05	180	137	6	0f9b27054358c4737eed06c8ea01987cccc3cb55
ToppCell	COVID-19-Heart-EC_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VWF THSD7A PKP4 PTPRB FGD5 MMP16	2.20e-05	183	137	6	ff95382cfed592190d0636d2b750328471f82e0d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 FREM2 FAT1 TRANK1 ADAMTS16 USH2A	2.27e-05	184	137	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	VWF THSD7A LAMA3 MYOF PTPRB FGD5	2.27e-05	184	137	6	087666ba949b129c53d7ace40f9e543e3875a7de
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 FREM2 FAT1 TRANK1 ADAMTS16 USH2A	2.27e-05	184	137	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 FREM2 FAT1 TRANK1 ADAMTS16 USH2A	2.27e-05	184	137	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF5 TEAD4 PTPRB PLXNC1 ACMSD TRIM37	2.34e-05	185	137	6	bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VWF THSD7A PTPRB FGF2 FBLIM1 MMP16	2.34e-05	185	137	6	a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCell	droplet-Heart-nan-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1A1 VWF PRAG1 PTPRB FGD5 TRIM37	2.34e-05	185	137	6	a32d5cb596ebac80eb1ac301055e65d420879ec8
ToppCell	Control-Myeloid-MoAM3,_VCAN\|Myeloid / Condition, Lineage and Cell class	ANXA6 LAMA3 RYR3 S100A10 PLXNC1 SERINC5	2.42e-05	186	137	6	0bf16ac48931b62bb3c33d63ff4279654148e293
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AMD1 VWF THSD7A PTPRB FGD5 MMP16	2.42e-05	186	137	6	2d3a975d2bf92e18e3410dd413fc9f84831d82de
ToppCell	droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF THSD7A LAMA3 ADH7 PTPRB FGD5	2.42e-05	186	137	6	5d0cd07b6b51e8ce9e1da949f757dc4575ec5752
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF704 VWF THSD7A LAMA3 PTPRB FBLIM1	2.42e-05	186	137	6	1e67bfb248366d7395efdd2d5e70a97bdb2e68af
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF704 VWF LAMA3 ADH7 MYOF FBLIM1	2.42e-05	186	137	6	c116cc9f41971622264434ebe29d18e719b0ae19
ToppCell	P28-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KLHL6 CYP1A1 VWF S100A10 PTPRB MMP16	2.42e-05	186	137	6	153c8b2fd8a6e2141ca97c626f82e5f081f3180a
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF704 VWF THSD7A LAMA3 PTPRB FBLIM1	2.42e-05	186	137	6	ffbc78058be8f0dc2e0335cc4c3195a636d17721
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZNF704 VWF THSD7A LAMA3 PTPRB FBLIM1	2.42e-05	186	137	6	ed924852cd7132c8f6703522037dc22bd2c83193
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA3 PRAG1 ITGB6 MYOF FGF2 COL14A1	2.49e-05	187	137	6	87b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA3 PRAG1 ITGB6 MYOF FGF2 COL14A1	2.49e-05	187	137	6	42a1267bfc27b4460b8409ada580a87c4385841c
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP1A1 VWF S100A10 PTPRB FGD5 MMP16	2.49e-05	187	137	6	6cf7be5401b81a4eeb30840fb3733d61a24af539
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA3 PRAG1 ITGB6 MYOF FGF2 COL14A1	2.49e-05	187	137	6	64afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	AMD1 VWF THSD7A PTPRB FGF2 FGD5	2.49e-05	187	137	6	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175\|Adult / Lineage, Cell type, age group and donor	VWF TEAD4 FAT1 PTPRB PRKCE FGD5	2.49e-05	187	137	6	f3548817f2fded5978137bb252cb628ac199e4f6
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP1A1 VWF S100A10 PTPRB FGD5 MMP16	2.49e-05	187	137	6	63834420db930df91b62494c9d7aaa9a25bca530
ToppCell	droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF THSD7A ADH7 PTPRB FGD5 RPL10	2.49e-05	187	137	6	e93cad16a087d1443cbf4e1690dc1b35d7a84c41
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LAMA3 PRAG1 ITGB6 MYOF SEMA3B SEMA3E	2.57e-05	188	137	6	eea652bab161f19148a883e7e3fe2523b36b3cea
ToppCell	droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD7A PGR ADH7 PTPRB FGD5 RPL10	2.57e-05	188	137	6	ec0e241de2c8310b4417b9d4e2420d7a1662f1c0
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	MTHFD1L LAMA3 RYR3 MYOF COL14A1 FBLIM1	2.57e-05	188	137	6	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VWF THSD7A PKP4 RYR3 PTPRB FGD5	2.64e-05	189	137	6	c121817ddad164e9cfe382c43d0cbc9215508d02
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	MTHFD1L LAMA3 RYR3 MYOF COL14A1 FBLIM1	2.64e-05	189	137	6	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	E17.5-Endothelial-large_vessel_endothelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	AMD1 VWF THSD7A PTPRB FGD5 MMP16	2.64e-05	189	137	6	360f09f46231a83f99d8fa0158b72a38068e1642
ToppCell	droplet-Bladder\|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHLDA1 CLDN7 MYOF LRP1 DDX3Y GRHL3	2.72e-05	190	137	6	170484f7a6f0a0d0792bbe1bb04abad060b7188e
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	AMD1 VWF THSD7A PTPRB FGD5 MMP16	2.72e-05	190	137	6	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	KLHL6 VWF S100A10 PTPRB COL14A1 MMP16	2.72e-05	190	137	6	d072bb285bd34d518b958e7c9ad44739c60b359c
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery\|Children_(3_yrs) / Lineage, Cell type, age group and donor	VWF THSD7A PTPRB FGF2 FBLIM1 MMP16	2.72e-05	190	137	6	f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	VWF THSD7A PTPRB FGF2 FGD5 FBLIM1	2.80e-05	191	137	6	50601ef0a5a8f2c2120922989e08e85bf2d9b4ab
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP1A1 VWF PTPRB ADAMTS18 COL14A1 MMP16	2.80e-05	191	137	6	fcdf3a747038e346a467eae8b7c293592658b53f
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1A1 VWF THSD7A PTPRB FGD5 MMP16	2.80e-05	191	137	6	9fc674a58f20b47255e4457d5195c8cff17b0414
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NAALAD2 PGR ADAMTS12 LRP1 COL14A1 FBLIM1	2.80e-05	191	137	6	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NAALAD2 PGR ADAMTS12 ADAMTS16 COL14A1 SEMA3E	2.80e-05	191	137	6	fa380a8752de158974b2ae5e741573439719cc0d
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VWF THSD7A PTPRB COL14A1 FGD5 MMP16	2.80e-05	191	137	6	b270c3dd5952f56b9bdceabe13e298fe6757563b
ToppCell	droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1A1 VWF THSD7A PTPRB FGD5 MMP16	2.80e-05	191	137	6	c379a499dabf3c9ed80f47adbb2d949821c5b053
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	VWF PKP4 TEAD4 PRAG1 PTPRB FGD5	2.80e-05	191	137	6	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD7A LAMA3 PTPRB FGD5 FBLIM1 RPL10	2.80e-05	191	137	6	b9ae5af426e7a1f2652a47700bb168371bd2dec6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NAALAD2 PGR ADAMTS12 LRP1 COL14A1 FBLIM1	2.80e-05	191	137	6	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Tcf7l2_(Substantia_Innominata_(SI))\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CRACR2A MAB21L2 BTN1A1 MAB21L1	2.87e-05	57	137	4	eab63d89e2100bb94fb026f700c2f82d657f92c1
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Tcf7l2_(Substantia_Innominata_(SI))-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CRACR2A MAB21L2 BTN1A1 MAB21L1	2.87e-05	57	137	4	2dc04513910af16d2cd84b3ae5b8d4c831124c68
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYP1A1 VWF THSD7A PTPRB FGD5 MMP16	2.89e-05	192	137	6	1990dc8a81594018a5bf596be99d0b5f0af0f58f
ToppCell	Control-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	VWF THSD7A MYOF PTPRB FGF2 FBLIM1	2.89e-05	192	137	6	7e89b9125e8b85f6be85eeccef5c8644647ab0e1
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYP1A1 VWF THSD7A PTPRB FGD5 MMP16	2.89e-05	192	137	6	845cc9c18b4436b07dd3ce7980052683937546d2
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VWF LAMA3 PTPRB FGD5 PREX1 AGTPBP1	2.89e-05	192	137	6	3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91
ToppCell	droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYP1A1 VWF THSD7A PTPRB FGD5 MMP16	2.89e-05	192	137	6	c72a082c93a8825adbfef37f889ba3a7052f201b
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	UGT1A6 ITGB6 RYR1 ADH7 S100A10 MYOF	2.97e-05	193	137	6	7c34abdcb8839b9fb25457a79af6c5e7b9714b21
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF PKP4 PTPRB PRKCE FGD5 MMP16	2.97e-05	193	137	6	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	facs-MAT-Fat-3m-Endothelial\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1A1 VWF PKP4 PTPRB FGD5 TRIM37	2.97e-05	193	137	6	b32533afeff1905e188becaa09079e9699722e4b
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWF PKP4 PTPRB PRKCE FGD5 MMP16	2.97e-05	193	137	6	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	facs-MAT-Fat-3m-Endothelial-nan\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1A1 VWF PKP4 PTPRB FGD5 TRIM37	2.97e-05	193	137	6	2ff573ba2c74583ed1cb071a3bbc01bb71117e5f
ToppCell	Control-Endothelial-VE_Arterial\|World / Disease state, Lineage and Cell class	CYP1A1 VWF THSD7A TEAD4 PTPRB FGF2	2.97e-05	193	137	6	52c0f2c7af57436f23e0c0e0c87086c47695e2c4
ToppCell	facs-MAT-Fat-3m-Endothelial-endothelial_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1A1 VWF PKP4 PTPRB FGD5 TRIM37	2.97e-05	193	137	6	e164f6403a8b541ced08a6feec915d2e855036ea
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	VWF RYR3 PTPRB FGF2 FGD5 PREX1	2.97e-05	193	137	6	0b328f725f6feba263783eaca60c142e80df90f3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL6 DOCK8 STK17B RYR1 PLXNC1 PREX1	3.06e-05	194	137	6	96f16bcd393a0d3f8df479b172b5360ae5a1e663
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CELF4 PGR TRANK1 PRKCE HERC1 AGTPBP1	3.06e-05	194	137	6	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	THSD7A PGR ADAMTS12 MYOF COL14A1 MMP16	3.06e-05	194	137	6	5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36
Drug	8-prenylnaringenin	CYP1A1 CYP1A2 VWF UGT1A6 ESRRA PGR SAFB2	2.48e-08	52	136	7	CID000480764
Drug	phosphonoacetaldehyde	ESRRA IREB2 PGR PRSS27 SAFB2 PRKCE SERINC5 ACMSD	3.72e-07	112	136	8	CID000000490
Drug	N-desmethyl-tamoxifen-hydrochloride	CYP1A1 CYP1A2 ESRRA PGR SAFB2 PRKCE	6.60e-07	52	136	6	CID000035887
Drug	AC1Q6OQF	CYP1A1 CYP1A2 UGT1A6 ESRRA SAFB2 RPL10	9.27e-07	55	136	6	CID000009685
Drug	hydroxyl radicals	CYP1A1 CYP1A2 VWF PTCHD3 ACADVL AUH MYCBP2 MTHFD1L PGAM2 ADH7 GTF2E1 PTPRB LRP1 PRKCE PLA2G6 OXSM ACMSD PC ATP2A1 ANAPC5 TRIM37 ATP4B RPL10 USP47	1.27e-06	1341	136	24	CID000000961
Drug	2,4,6-triphenyl-1-hexene	CYP1A1 CYP1A2 UGT1A6	2.07e-06	5	136	3	ctd:C533342
Drug	6-hydroxychrysene	CYP1A1 UGT1A6 PGR	2.07e-06	5	136	3	ctd:C087203
Drug	6-NCDF	CYP1A1 CYP1A2 PGR	4.12e-06	6	136	3	CID000130492
Drug	chlorotoluron	CYP1A1 CYP1A2 OXSM GRHL3	6.74e-06	21	136	4	CID000027375
Drug	AC1L2JTN	ESRRA PGR PRSS27 SAFB2	6.74e-06	21	136	4	CID000022150
Drug	4-hydroxyestradiol	CYP1A1 CYP1A2 UGT1A6 ESRRA PGR SAFB2	7.90e-06	79	136	6	CID000001743
Drug	Fura-2AM	TRPM7 RYR1 RYR3 PRKCE PLA2G6 ATP2A1	7.90e-06	79	136	6	CID000105091
Drug	triphenylethylene	ESRRA PGR SAFB2 PRKCE TAF1	7.95e-06	46	136	5	CID000006025
Drug	8-prenylnaringenin	CYP1A1 CYP1A2 VWF PGR	8.20e-06	22	136	4	ctd:C119737
Drug	TMB-8	TRIM39 RYR1 RYR3 MAP4K5 PRKCE PLA2G6 ATP2A1 ALOX12B	1.10e-05	176	136	8	CID000005494
Drug	1,7-phenanthroline	CYP1A1 CYP1A2 UGT1A6	1.14e-05	8	136	3	ctd:C053486
Drug	U23,469	ESRRA PGR SAFB2	1.71e-05	9	136	3	CID000161922
Drug	pentachlorobiphenyl	CYP1A1 CYP1A2 RYR1	1.71e-05	9	136	3	CID000017348
Drug	nafoxidine	ESRRA PGR SAFB2 TAF1	1.92e-05	27	136	4	CID000004416
Drug	MCDF	CYP1A1 ESRRA PGR SAFB2	2.23e-05	28	136	4	CID000114900
Drug	Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A	ATAD5 ESRRA ITGB6 ZFYVE9 MAP4K5 SAFB2 TAF1 DNMT3A	2.40e-05	196	136	8	6229_UP
Drug	PCB 95	CYP1A1 RYR1 RYR3	2.43e-05	10	136	3	CID000038012
Drug	U-62066 [87151-85-7]; Up 200; 1uM; PC3; HT_HG-U133A	CYP1A2 STK17B MRPS18C LRP1 PRKCE MMP16 ALOX12B DNMT3A	2.58e-05	198	136	8	4553_UP
Drug	indo-1	ACADVL RYR1 RYR3 FAT1 PRKCE ATP2A1	2.89e-05	99	136	6	CID000105060
Drug	mS60	CYP1A1 CYP1A2 TRIM39 GTF2E1	2.96e-05	30	136	4	CID000013078
Drug	AC1ND2OB	CYP1A1 CYP1A2 UGT1A6 ESRRA PGR SAFB2 PRMT1 PRKCE TAF1	3.16e-05	265	136	9	CID004568637
Drug	3,4,3',4'-tetrachloroazobenzene	CYP1A1 CYP1A2 PGR	3.32e-05	11	136	3	ctd:C013279
Drug	4-ethylphenol	UGT1A6 RYR1 PRSS27 TRIM37	3.38e-05	31	136	4	CID000031242
Drug	2-methoxy-4-aminoazobenzene	CYP1A1 CYP1A2	3.54e-05	2	136	2	ctd:C053767
Drug	3,4,3',4'-tetrachloroazoxybenzene	CYP1A1 CYP1A2	3.54e-05	2	136	2	ctd:C013280
Drug	5'-adenylyl (beta,gamma-methylene)diphosphonate	RYR1 RYR3	3.54e-05	2	136	2	ctd:C005147
Drug	cloflucarban	CYP1A1 CYP1A2	3.54e-05	2	136	2	ctd:C005055
Drug	musk xylene	CYP1A1 CYP1A2	3.54e-05	2	136	2	ctd:C031447
Drug	sesamex	CYP1A1 CYP1A2	3.54e-05	2	136	2	ctd:C100180
Drug	Canthaxanthin	CYP1A1 CYP1A2	3.54e-05	2	136	2	ctd:D016644
Drug	Pigment Yellow 74	CYP1A1 CYP1A2	3.54e-05	2	136	2	CID000022829
Drug	pyridoxal isonicotinoyl hydrazone	CYP1A1 CYP1A2	3.54e-05	2	136	2	ctd:C021079
Drug	nitroaniline	CYP1A1 CYP1A2	3.54e-05	2	136	2	ctd:C008625
Drug	7H-dibenzo(c,g)carbazole	CYP1A1 CYP1A2	3.54e-05	2	136	2	ctd:C013478
Drug	2,7-dinitrofluorene	CYP1A1 CYP1A2	3.54e-05	2	136	2	ctd:C085049
Drug	beta-apo-8'-carotenal	CYP1A1 CYP1A2	3.54e-05	2	136	2	ctd:C110652
Drug	propachlor	CYP1A1 CYP1A2	3.54e-05	2	136	2	ctd:C011088
Drug	allocryptopine	CYP1A1 CYP1A2	3.54e-05	2	136	2	ctd:C109505
Drug	2,7-FAA	CYP1A1 CYP1A2	3.54e-05	2	136	2	CID000009352
Drug	protopine	CYP1A1 CYP1A2	3.54e-05	2	136	2	ctd:C009093
Drug	2-hydroxyestradiol	CYP1A1 CYP1A2 UGT1A6 ESRRA SAFB2	3.76e-05	63	136	5	CID000009684
Drug	butyl benzyl phthalate	ESRRA PATE1 PGR SAFB2	3.85e-05	32	136	4	CID000002347
Drug	o,p'-DDE	CYP1A1 ESRRA PGR SAFB2	3.85e-05	32	136	4	CID000246598
Drug	isoflavone	CYP1A1 CYP1A2 ESRRA PGR SAFB2 SPDEF MMP16	4.14e-05	155	136	7	CID000072304
Drug	phosphine oxide	GARS1 RYR1 RYR3 PRKCE OXSM PC	4.48e-05	107	136	6	CID000166931
Drug	Methylcholanthrene	CYP1A1 CYP1A2 UGT1A6 TRIM39 TEAD4 RYR3 PGR ADAMTS12 ADH7 FREM2 MYOF RABL2A UMODL1 PREX1 PLK4 SMYD3 RPL10 DNMT3A	4.49e-05	1034	136	18	ctd:D008748
Drug	4-(3,6-dimethylheptan-3-yl)phenol	ESRRA PGR SAFB2 TAF1	4.91e-05	34	136	4	CID010633340
Drug	formononetin	CYP1A2 ESRRA PGR SAFB2	4.91e-05	34	136	4	CID005280378
Drug	strontium	TRPM7 RYR1 RYR3 PRKCE ATP2A1	5.44e-05	68	136	5	CID000104798
Drug	DP-TAT-59	ESRRA PGR SAFB2	5.71e-05	13	136	3	CID003037015
Drug	ketononestrol aziridine	ESRRA PGR SAFB2	5.71e-05	13	136	3	CID000130642
Drug	2-phenylindole	ESRRA SAFB2 TAF1	5.71e-05	13	136	3	CID000013698
Drug	vinylidene chloride	CYP1A1 CYP1A2 AUH PHLDA1 DOCK8 ATAD5 MTHFD1L STK17B PGAM2 FREM2 MYOF FAT1 PTPRB SEMA3B LRP1 PRKCE FGD5 RAB11FIP4 FBLIM1 KLKB1 PLK4 SEMA3E	6.22e-05	1475	136	22	ctd:C029297
Drug	BAPTA-AM	VWF STK17B CAMP ANXA6 RYR1 RYR3 FAT1 PRKCE ATP2A1	6.88e-05	293	136	9	CID000002293
Drug	anastrozole	CYP1A2 ESRRA PGR SAFB2	6.90e-05	37	136	4	CID000002187
Drug	mag-fura-2	TRPM7 RYR1 RYR3 ATP2A1	6.90e-05	37	136	4	CID000123839
Drug	estrone-d4	CYP1A1 CYP1A2 TRPM7 UGT1A6 ESRRA PGR SAFB2	6.90e-05	168	136	7	CID000000698
Drug	felodipine	CYP1A1 CYP1A2 CAMP TRIM39 RYR1 RYR3 PGR	7.17e-05	169	136	7	CID000003333
Drug	methoxychlor	CYP1A1 CYP1A2 ESRRA PGR SAFB2	7.17e-05	72	136	5	CID000004115
Drug	AC1L1JVU	TRPM7 RYR1 RYR3 PRKCE ATP2A1	7.17e-05	72	136	5	CID000005229
Drug	2,2,2-trichloroethanol	CYP1A1 CYP1A2 UGT1A6 ADH7 OXSM	7.66e-05	73	136	5	CID000008259
Drug	AC1L1AS8	VWF PTCHD3 ACADVL MSH6 PRKCE PLA2G6 OXSM	8.61e-05	174	136	7	CID000001126
Drug	erucin	CYP1A1 CYP1A2 UGT1A6	9.00e-05	15	136	3	ctd:C073539
Drug	glufosinate	IREB2 RYR1 BTN1A1 LRP1 PRKCE	9.29e-05	76	136	5	CID000004794
Drug	Demetric acid	ESRRA PALB2 PGR SAFB2	9.42e-05	40	136	4	CID000025440
Drug	Dantrolene	CYP1A1 CYP1A2 RYR1 RYR3	1.04e-04	41	136	4	ctd:D003620
Drug	2,3-diaminotoluene	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:C100420
Drug	2-amino-1-methyl-6-phenyl-1H-imidazo(4,5-b)pyridine	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:C522525
Drug	2-amino-1,7-dimethylimidazo(4,5-g)quinoxaline	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:C519626
Drug	scutellarein	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:C458179
Drug	genkwanin	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:C014568
Drug	cis-diammineplatinum(II	RYR1 RYR3	1.06e-04	3	136	2	CID000159790
Drug	methylthymol blue	OXSM TRIM37	1.06e-04	3	136	2	CID000073037
Drug	1-methoxyrutaecarpine	CYP1A1 CYP1A2	1.06e-04	3	136	2	CID005319487
Drug	2-hydroxyheptanoic acid	RYR1 RYR3	1.06e-04	3	136	2	CID002750949
Drug	Suppressor Factors, Immunologic	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:D013491
Drug	8N3-cADPR	RYR1 RYR3	1.06e-04	3	136	2	CID000127713
Drug	alyssin	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:C524316
Drug	2-oxohexyl isothiocyanate	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:C524315
Drug	aminodantrolene	RYR1 RYR3	1.06e-04	3	136	2	CID009570289
Drug	Trichloroepoxypropane	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:D014239
Drug	3-aminofluorene	CYP1A1 CYP1A2	1.06e-04	3	136	2	CID000022818
Drug	1-aminofluorene	CYP1A1 CYP1A2	1.06e-04	3	136	2	CID000022817
Drug	2,2',4,6'-tetramethoxystilbene	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:C541980
Drug	6-nitrobenzo(a)pyrene	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:C034699
Drug	chlortoluron	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:C007033
Drug	Aminoquinolines	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:D000634
Drug	2-hydroxycarbazole	RYR1 RYR3	1.06e-04	3	136	2	CID000093551
Drug	1,1'-diheptyl-4,4'-bipyridinium	RYR1 RYR3	1.06e-04	3	136	2	CID000080262
Drug	2,3,6,7-tetrachlorobiphenylene	CYP1A1 PC	1.06e-04	3	136	2	CID000081533
Drug	7-(deoxyadenosin-N(6)--yl)aristolactam II	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:C405699
Drug	1,2,3,7,8-pentachlorodibenzofuran	CYP1A1 CYP1A2	1.06e-04	3	136	2	ctd:C057584
Drug	flubendiamide	RYR1 RYR3	1.06e-04	3	136	2	CID011193251
Drug	AC1O3FH2	GTF2E1 TRIM37	1.06e-04	3	136	2	CID006327294
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR1 RYR3	1.06e-04	3	136	2	CID005748312
Disease	anxiety, vitamin D measurement	DOCK8 SMYD3 SEMA3E	3.16e-06	7	134	3	EFO_0004631, EFO_0005230
Disease	plasma clozapine measurement	CYP1A1 CYP1A2 UGT1A6	5.04e-06	8	134	3	EFO_0600038
Disease	plasma N-desmethylclozapine measurement	CYP1A1 CYP1A2 UGT1A6	1.47e-05	11	134	3	EFO_0600039
Disease	5-hydroxy-2-methylpyridine sulfate measurement	CYP1A1 CYP1A2	2.05e-05	2	134	2	EFO_0801051
Disease	serum clozapine measurement	CYP1A1 CYP1A2	2.05e-05	2	134	2	EFO_0600041
Disease	coffee consumption, cups of coffee per day measurement	CYP1A1 CYP1A2 MAP4K5	4.91e-05	16	134	3	EFO_0004330, EFO_0006782
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR3	6.12e-05	3	134	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR3	6.12e-05	3	134	2	DOID:8545 (implicated_via_orthology)
Disease	tetradecenoylcarnitine meaasurement	ACADVL ALOX12B	6.12e-05	3	134	2	EFO_0021809
Disease	caffeine metabolite measurement	CYP1A1 CYP1A2 MAP4K5	8.41e-05	19	134	3	EFO_0007872
Disease	hair morphology measurement	THSD7A PRAG1 S100A10 PLXNC1	1.08e-04	54	134	4	EFO_0007821
Disease	X-21286 measurement	CYP1A1 CYP1A2	1.22e-04	4	134	2	EFO_0800804
Disease	complement factor H-like 1 protein measurement	THSD7A FREM2 KLKB1	1.32e-04	22	134	3	EFO_0600092
Disease	forced expiratory volume	THSD7A ATAD5 IREB2 PABPC4L TRIM39 CLDN7 SEC24C CROCC2 ATAD2B PC PREX1 SLC25A31	2.64e-04	789	134	12	EFO_0004314
Disease	porphyria cutanea tarda (is_implicated_in)	CYP1A1 CYP1A2	3.03e-04	6	134	2	DOID:3132 (is_implicated_in)
Disease	1-palmitoyl-GPE (16:0) measurement	MAP4K5 TP53BP1	4.24e-04	7	134	2	EFO_0800245
Disease	Amelogenesis imperfecta local hypoplastic form	LAMA3 ITGB6	4.24e-04	7	134	2	C0399367
Disease	body mass index, fasting blood insulin measurement	PTCHD3 MAP4K5 GRHL3	4.52e-04	33	134	3	EFO_0004340, EFO_0004466
Disease	birth weight	ATAD5 PABPC4L CLDN7 UMODL1 ATAD2B PLA2G6 USH2A PREX1	4.94e-04	399	134	8	EFO_0004344
Disease	triglyceride measurement, metabolic syndrome	MAP4K5 ZNF512	5.63e-04	8	134	2	EFO_0000195, EFO_0004530
Disease	endometrial cancer (is_implicated_in)	CYP1A1 CYP1A2 MSH6	5.86e-04	36	134	3	DOID:1380 (is_implicated_in)
Disease	venous thromboembolism, factor VII measurement	VWF ADH7 MAP4K5	6.88e-04	38	134	3	EFO_0004286, EFO_0004619
Disease	advanced glycation end-product measurement	CYP1A1 CYP1A2	7.22e-04	9	134	2	EFO_0007819
Disease	cups of coffee per day measurement	CYP1A1 CYP1A2 MAP4K5	8.00e-04	40	134	3	EFO_0006782
Disease	theophylline measurement	CYP1A1 CYP1A2	8.99e-04	10	134	2	EFO_0021180
Disease	sweet beverage consumption measurement	CYP1A1 CYP1A2	8.99e-04	10	134	2	EFO_0010090
Disease	1,7-dimethylurate measurement	CYP1A1 CYP1A2	8.99e-04	10	134	2	EFO_0021512
Disease	bitter beverage consumption measurement	CYP1A1 CYP1A2 MAP4K5	9.24e-04	42	134	3	EFO_0010089
Disease	coffee consumption measurement, tea consumption measurement	CYP1A1 CYP1A2 MAP4K5	1.06e-03	44	134	3	EFO_0006781, EFO_0010091
Disease	1-methylxanthine measurement	CYP1A1 CYP1A2	1.10e-03	11	134	2	EFO_0021174
Disease	peptidyl-glycine alpha-amidating monooxygenase measurement	MYCBP2 KLKB1	1.10e-03	11	134	2	EFO_0801871
Disease	5-acetylamino-6-amino-3-methyluracil measurement	CYP1A1 CYP1A2	1.10e-03	11	134	2	EFO_0800951
Disease	neuroticism measurement, response to selective serotonin reuptake inhibitor	CELF4 PLXNC1	1.10e-03	11	134	2	EFO_0005658, EFO_0007660
Disease	response to virus	CRACR2A FREM2	1.10e-03	11	134	2	GO_0009615
Disease	osteosarcoma (is_marker_for)	MSH6 PTPRB	1.10e-03	11	134	2	DOID:3347 (is_marker_for)
Disease	follistatin measurement	MAP4K5 TP53BP1	1.10e-03	11	134	2	EFO_0010614
Disease	esophagus squamous cell carcinoma (is_implicated_in)	CYP1A1 FAT1 COL14A1	1.13e-03	45	134	3	DOID:3748 (is_implicated_in)
Disease	paraxanthine measurement	CYP1A1 CYP1A2	1.31e-03	12	134	2	EFO_0021178
Disease	Bipolar Disorder	THSD7A PALB2 S100A10 TRANK1 SEC24C TLL2 PLA2G6 PC	1.56e-03	477	134	8	C0005586
Disease	lysophosphatidylcholine 16:1 measurement	MAP4K5 ZNF512	1.80e-03	14	134	2	EFO_0010358
Disease	level of Phosphatidylethanolamine (18:2_0:0) in blood serum	MAP4K5 ZNF512	1.80e-03	14	134	2	OBA_2045143
Disease	Hepatomegaly	CYP1A1 CYP1A2 TRIM37	1.92e-03	54	134	3	C0019209
Disease	1,3,7-trimethylurate measurement	CYP1A1 CYP1A2	2.07e-03	15	134	2	EFO_0021172
Disease	liver volume	MAP4K5 TP53BP1	2.07e-03	15	134	2	EFO_0600048
Disease	urate measurement, bone density	CRACR2A MTHFD1L UGT1A6 ITGB6 FSIP2 PLXNC1 MAP4K5 ADAMTS16 USH2A	2.13e-03	619	134	9	EFO_0003923, EFO_0004531
Disease	Endometrial Neoplasms	PGR MSH6 SEMA3B	2.35e-03	58	134	3	C0014170
Disease	Cannabis use	ZNF704 ATP2A1	2.36e-03	16	134	2	EFO_0007585
Disease	breast carcinoma	ZNF704 CYP1A1 ATAD5 ARHGEF5 PALB2 PLXNC1 ADAMTS16 COL14A1 PLA2G6 PRORP AGTPBP1 DNMT3A	2.40e-03	1019	134	12	EFO_0000305
Disease	cholesteryl esters to total lipids in large HDL percentage	PSKH1 MAP4K5 TP53BP1	2.47e-03	59	134	3	EFO_0022248
Disease	diffuse plaque measurement	TMPRSS9 DOCK8 PKP4 MSH6 PLXNC1 ADAMTS18 SPDEF COL14A1 SMYD3 AGTPBP1	2.47e-03	758	134	10	EFO_0010699
Disease	nevus count	DOCK8 PLA2G6	2.99e-03	18	134	2	EFO_0004632
Disease	diet measurement	CYP1A1 CYP1A2 CELF4 KCTD8 PABPC4L ADH7 MSH6 TRANK1 MAP4K5 BTN1A1 MED27 DNMT3A	3.04e-03	1049	134	12	EFO_0008111
Disease	ovarian neoplasm	MSH6 SPDEF ALOX12B TP53BP1	3.31e-03	134	134	4	C0919267
Disease	histidine measurement	MAP4K5 KLKB1 TP53BP1	3.40e-03	66	134	3	EFO_0009769
Disease	depressive symptom measurement	CELF4 VWF ATAD2B BTN1A1 SEMA3B HERC1 SEMA3E	3.40e-03	426	134	7	EFO_0007006
Disease	Malignant neoplasm of ovary	MSH6 SPDEF ALOX12B TP53BP1	3.58e-03	137	134	4	C1140680
Disease	Malignant neoplasm of breast	CYP1A1 VWF ESRRA PALB2 PGR MSH6 UTP20 OXSM FGD5 ANAPC5 TP53BP1 DNMT3A	3.67e-03	1074	134	12	C0006142
Disease	alpha-tocopherol measurement	PRKCE USH2A	3.69e-03	20	134	2	EFO_0007898
Disease	response to ketamine	DOCK8 MMP16 ALOX12B	3.86e-03	69	134	3	EFO_0009748
Disease	Lung Injury	CYP1A1 CYP1A2	4.06e-03	21	134	2	C0273115
Disease	Chronic Lung Injury	CYP1A1 CYP1A2	4.06e-03	21	134	2	C2350344
Disease	metabolite measurement	ACADVL UGT1A6 S100A10 MYOF MAP4K5 ACMSD ZNF512 KLKB1	4.15e-03	560	134	8	EFO_0004725
Disease	Manic Disorder	THSD7A TRANK1 PC	4.18e-03	71	134	3	C0024713
Disease	Endometrial Carcinoma	PGR MSH6 SEMA3B	4.35e-03	72	134	3	C0476089
Disease	stomach cancer (is_implicated_in)	CYP1A1 ATP4B DNMT3A	4.35e-03	72	134	3	DOID:10534 (is_implicated_in)
Disease	Seckel syndrome	PLK4 DNMT3A	4.46e-03	22	134	2	C0265202
Disease	colorectal carcinoma (is_implicated_in)	MSH6 PTPRB	4.46e-03	22	134	2	DOID:0080199 (is_implicated_in)
Disease	leucine measurement	PRAG1 MAP4K5 KLKB1	4.52e-03	73	134	3	EFO_0009770

Protein segments in the cluster

Peptide	Gene	Start	Entry
CFGDNKVKMEVCRLG	PKP4	556	Q99569
LVEIMAKACGKEGAR	UMODL1	766	Q5DID0
DRMGTAGKVIKCKAA	ADH7	11	P40394
CKAKRDFLMSGLPDL	ATAD5	831	Q96QE3
KAVDDACKLMGERKF	CXorf58	141	Q96LI9
FGDGKFSVVCVEKLM	DNMT3A	331	Q9Y6K1
AIGVCRENVMKKGFD	BTN1A1	371	Q13410
KEVMGGFSRRCSKLI	ARHGEF5	1076	Q12774
VKEMERCVKELGFPG	ACMSD	126	Q8TDX5
CAMKEAFGFIERGDV	CSDE1	191	O75534
TCDAEGKGFIARKDM	CRACR2A	61	Q9BSW2
GFCKIVGRSKDMIIR	ACSF2	501	Q96CM8
GFEEGKPCFIIKMNR	ATP4B	171	P51164
ADIGMEKFFNIKCRA	MTHFD1L	716	Q6UB35
RELEEMGAKFCVGLL	AGTPBP1	1121	Q9UPW5
KMFVKGAPEGVIDRC	ATP2A1	511	O14983
CIKKGRGMVKATFCD	ADAMTS12	851	P58397
IGRKCETKFMPAAEG	ADAMTS16	546	Q8TE57
GVRKREMKCSEKGFQ	ADAMTS18	1071	Q8TE60
ILCMFAAKAGARKVI	PRMT1	101	Q99873
GDFEKLMLAVVKCIR	ANXA6	236	P08133
RGVFAMKGCEELLKD	RAB11FIP4	76	Q86YS3
KVIIFGMGKRKCIGE	CYP1A1	446	P04798
FGMGKRRCIGEVLAK	CYP1A2	451	P05177
LEAAVRNCDGFLMKK	IREB2	46	P48200
CLGDSAVGKSKLMER	RABL2A	26	Q9UBK7
CLGDSAVGKSKLMER	RABL2B	26	Q9UNT1
AILDKGRAMFLVAKC	ANAPC5	656	Q9UJX4
EDCRMGAGIAVLFKK	OARD1	36	Q9Y530
GEGALRCMAAALKDA	OXSM	321	Q9NWU1
VRLMAKDAGGKVAFC	FAT1	2566	Q14517
IKLGAEMESLGGKCD	PTPRB	1546	P23467
MVCGRIALAKEVFGD	KCTD8	236	Q6ZWB6
FMIIGGCTKDERFVA	KLHL6	321	Q8WZ60
KVDCLKEFGREANMA	LAMA3	191	Q16787
IFCAGADLKERAKMS	AUH	136	Q13825
CRRGMKAKQLKAEAG	HHLA3	71	Q9XRX5
CKLADFGMCKEGILN	PRKCE	546	Q02156
LKCARMPGLKGFVDE	LRP1	256	Q07954
GDKKVAFFMRKGADC	ATAD2B	461	Q9ULI0
AVLMCRGKESFRGKD	FREM2	3131	Q5SZK8
DMGGDLRKCSFIKLE	HERC1	3411	Q15751
GLASARKKGDDCLMK	PSKH1	241	P11801
FFGLLAGRFCMLKKE	CWC22	506	Q9HCG8
KFGVEMLGLIACFKA	DDX60L	621	Q5H9U9
GCSFLSKLAGFIMKE	FSIP2	5216	Q5CZC0
QGGKALMCVLRAFSK	MTIF3	231	Q9H2K0
SRKEMKDVCIQFDGG	PLXNC1	726	O60486
GGFDAIMQAAVCKEK	ITGB6	241	P18564
SFGCKVELEVLKGLM	SLC10A3	206	P09131
KDRMAKVCDGCFGEL	FGD5	1286	Q6ZNL6
HIGVKGMKFLCEALR	NLRP2	936	Q9NX02
VFDCLKDGMRNKETL	MED27	31	Q6P2C8
IDFLSALEGFKVMCK	MSH6	856	P52701
KMFGERHLKEGSCIF	PALB2	641	Q86YC2
KCEGGKAMLFTLKRD	OCR1	51	Q9BZK8
KCCQAGMVLGGRKFK	PGR	626	P06401
FKGLGDCIMKIAKSD	SLC25A31	166	Q9H0C2
DCIMKIAKSDGIAGL	SLC25A31	171	Q9H0C2
IKIFCDKGAERKMRD	GRHL3	396	Q8TE85
CFKEFIMRCGEAVEK	DOCK8	2016	Q8NF50
ASCKLLGREKAALEM	CROCC2	481	H7BZ55
CKAAKADLVFMVDGS	COL14A1	1026	Q05707
KIEGFKRLDCQSAMF	AMD1	301	P17707
DCDFKKDGLVKRCMG	CAMP	96	P49913
GCAVLKLSDGRKRSM	MAB21L2	96	Q9Y586
PMALAFKVRGLLDCK	ALOX12B	216	O75342
IPRDGKDAFKIECMG	FBLIM1	311	Q8WUP2
LAMKEDGRLLASKCV	FGF2	216	P09038
MEKRFGCFLKDSVTG	KLKB1	71	P03952
GMVFLKGKLGVCFDV	DDX21	671	Q9NR30
IIKGKRDLMACAQTG	DDX3Y	211	O15523
VDMMERGKIGLDFCK	DDX3Y	326	O15523
GMEALKAAECAGKLF	SEC24C	626	P53992
VKEDMETKCFICGIG	RYR1	4951	P21817
FTKCLRVGMLKEGVR	ESRRA	136	P11474
ITCFGAFMALDGKRE	PTCHD3	531	Q3KNS1
KVLMGACFSKVFDGC	MAP4K5	491	Q9Y4K4
KGFIIKQMKEDGACL	OTUD5	211	Q96G74
KQMKEDGACLFRAVA	OTUD5	216	Q96G74
FMGCLKNCADVKGIR	PATE1	91	Q8WXA2
DRAIEEMNGKLLKGC	PABPC4L	151	P0CB38
RKLEMLGAEKQGTFC	MED20	26	Q9H944
FIKCRMRVETAADGK	GTF2E1	71	P29083
EQGFGGCMKDVKFTR	USH2A	1856	O75445
CIFKFLGAVAMDLGI	UTP20	2646	O75691
RAKKSACSDMLLEGG	TRIM37	471	O94972
EVEGKCLQSGFEMLK	TRIM39	246	Q9HCM9
EKAVCGNGIKTRMLD	THSD7A	1236	Q9UPZ6
GCAVLKLSDGRKRSM	MAB21L1	96	Q13394
MVKSCGKDGFHIRVR	RPL10	76	P27635
RAFIAAMKGKCLLEV	TAF1	936	P21675
AMKGKCLLEVTGVAD	TAF1	941	P21675
GAKAIKDAKMEFDIC	PGAM2	41	P15259
VARSKCFLKMGDLER	ODAD4	51	Q96NG3
CFLKMGDLERSLKDA	ODAD4	56	Q96NG3
FMVKDVKNGECFRAD	GARS1	201	P41250
FPLVCGEGKKARVMA	PPM1J	361	Q5JR12
MDRSDHGGIKKVCFK	PREX1	1136	Q8TCU6
KIVDFGMSRKIGHAC	STK17B	176	O94768
GGVCAAALMKKDLAL	MYCBP2	2166	O75592
VFGAKELGKMVVDCC	PLA2G6	721	O60733
MATCIGEKIEDFKVG	PLK4	1	O00444
ECLKGKIMRDVIDGG	PRORP	366	O15091
MAAVVAVCGGLGRKK	MRPS18C	1	Q9Y3D5
GVVCDRCLLGKEKLM	SMYD3	46	Q9H7B4
MKDLDQCRDGKVGFQ	S100A10	56	P60903
CGEIKITDFGLSKIM	TLK2	606	Q86UE8
FVALQGCMDKGKELS	ACADVL	471	P49748
MFARGLKRKCVGHEE	CDCA4	1	Q9BXL8
LKDRFTGMHKGCAFL	CELF4	86	Q9BZC1
RCGGDDKVKKARIAM	CLDN7	106	O95471
GKVAFKNFSGEMCRL	UBTFL6	51	P0CB48
VLLIVKMAGRCKSGF	TMEM60	51	Q9H2L4
FDEHKCLAEGGKIMK	VWF	2696	P04275
LKDFMGCDGPTDRVK	MMP16	526	P51512
MKAFALGILKICDIA	NAA35	146	Q5VZE5
RMLESSGCKALKEGV	PHLDA1	141	Q8WV24
KTIKNDMLCAGFEEG	PRSS27	206	Q9BQR3
EKEMVAGLFCKLAAL	RYR3	2896	Q15413
GKDIGTECMNFVKLL	SEMA3B	106	Q13214
MGKAFQELAGKELCA	SPDEF	171	O95238
DMCKGIKAGDTCEKL	SERINC5	71	Q86VE9
EPCKFLLDAVFAKGM	USP47	1136	Q96K76
ADKKMCEVACGGFIT	TLL2	611	Q9Y6L7
LTDRMICAGFLEGKV	TMPRSS9	666	Q7Z410
AKRCVKGLKMEEEGT	SAFB2	86	Q14151
GAAPDVDDKLCLRMK	TP53BP1	976	Q12888
LVAKCEDLFMGGQKK	PRAG1	966	Q86YV5
CGRRKIILSDEGKMY	TEAD4	61	Q15561
EGKKCRKVYGMENRD	ZNF704	381	Q6ZNC4
IMKGKDAGECANYVR	SEMA3E	106	O15041
MNIDDKLEGLFLKCG	ZNF148	1	Q9UQR1
KLEGLFLKCGGIDEM	ZNF148	6	Q9UQR1
MVFIGGINCKKRKDL	UGT1A6	271	P19224
GVCMRFIVGLKCEDE	TRANK1	2146	O15050
RKLFALAKGECMEDN	POLR1B	351	Q9H9Y6
TMKVFAKRCDIGDAS	TUT4	1101	Q5TAX3
HVRKCGKGAAELEKM	ZNF512	271	Q96ME7
KFCEVAKENGMDVFR	PC	661	P11498
GLCAKIEFLSKEEMG	TRPM7	1606	Q96QT4
ALREMKDFTITCGKA	ZFYVE9	1241	O95405
TKVLCAHGGRMFLKD	ZC3HAV1L	11	Q96H79
FKLEREMGINCTGKI	NAALAD2	176	Q9Y3Q0
LRADCLMGEFKIDVG	MYOF	271	Q9NZM1